HAEMONETICS CORP - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2017-11-16

Reporting Person: GELBMAN RONALD G (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-16	Common Stock	M	5440	$34.405	Acquired	59457	Direct
2017-11-16	Common Stock	S	65	$56.57	Disposed	59392	Direct
2017-11-16	Common Stock	S	235	$56.58	Disposed	59157	Direct
2017-11-16	Common Stock	S	200	$56.60	Disposed	58957	Direct
2017-11-16	Common Stock	S	240	$56.62	Disposed	58717	Direct
2017-11-16	Common Stock	S	200	$56.63	Disposed	58517	Direct
2017-11-16	Common Stock	S	400	$56.65	Disposed	58117	Direct
2017-11-16	Common Stock	S	100	$56.66	Disposed	58017	Direct
2017-11-16	Common Stock	S	100	$56.665	Disposed	57917	Direct
2017-11-16	Common Stock	S	300	$56.67	Disposed	57617	Direct
2017-11-16	Common Stock	S	300	$56.68	Disposed	57317	Direct
2017-11-16	Common Stock	S	400	$56.69	Disposed	56917	Direct
2017-11-16	Common Stock	S	1200	$56.70	Disposed	55717	Direct
2017-11-16	Common Stock	S	100	$56.71	Disposed	55617	Direct
2017-11-16	Common Stock	S	100	$56.72	Disposed	55517	Direct
2017-11-16	Common Stock	S	400	$56.73	Disposed	55117	Direct
2017-11-16	Common Stock	S	300	$56.735	Disposed	54817	Direct
2017-11-16	Common Stock	S	300	$56.77	Disposed	54517	Direct
2017-11-16	Common Stock	S	200	$56.78	Disposed	54317	Direct
2017-11-16	Common Stock	S	300	$56.80	Disposed	54017	Direct
2017-11-16	Common Stock	M	1678	$34.405	Acquired	55695	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-16	Non-qualified Stock Option (Right to Buy)	$34.405	M	5440	Disposed	2018-07-21	Common Stock (5440)	Direct
2017-11-16	Non-qualified Stock Option (Right to Buy)	$34.405	M	1678	Disposed	2018-07-21	Common Stock (1678)	Direct

F1: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.